A global life sciences and healthcare company is closing a Massachusetts facility and laying off nearly 100 people.

U.S. House representatives heard the clinical lab industry plead yesterday for a reprieve from looming cuts as large as 15% ...

For the full fiscal year 2025, Wall Street analysts expect Labcorp’s diluted EPS to grow by 12% annually to $16.32, followed ...

The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

Quest and Labcorp may be archrivals in the diagnostic testing market, but they appear to agree on at least one thing: the ...

Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry ...

Labcorp is a global leader of innovative and comprehensive laboratory services. The company's Venture Fund invests in and supports early stage, private companies that are focused on improving health ...

LH's growth bets in specialty testing and acquisitions support its outlook, but macro pressures and currency headwinds remain ...

Company expands its ecosystem of investors with new financing from InHealth Ventures, part of a large UK-based health system, and the Labcorp Venture Fund IMVARIA Inc., a health tech company pioneerin ...

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted ...

Labcorp will host a fireside chat at the J.P. Morgan Healthcare Conference. Get details on the Labcorp investor conference, ...